Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety Study of TACE Plus Oral Songyou Granule for Unresectable HCC

NCT00805896 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT00805896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00805896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety Study of TACE Plus Oral Songyou Granule for Unresectable HCC
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2008
Completion date
December 31, 2010
Enrollment
260 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, unresectable